National Consumer Rights Law Firm FeganScott Files Second, Expanded Class-Action Lawsuit Against Allergan

“For decades, Allergan knew that its recalled implants were six times more likely to cause BIA-ALCL, but it continued to market these products, seemingly with little regard for the well-being of its users. Now, we’re expanding our complaint to more fully represent the extent of the alleged harm,” said Beth Fegan, founder and managing member of FeganScott.

Fegan noted that beginning in at least 2006, Allergan possessed information and evidence demonstrating that its recalled BIOCELL implants posed a significant risk of BIA-ALCL.

According to the complaint, Allergan violated state and federal law by failing to properly investigate, identify, disclose, warn of, and report the risks and adverse events associated with the implants.

Read the full article here.